berberine has been researched along with Angiogenesis, Pathologic in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Malignant melanoma is the most aggressive form of skin cancer." | 5.39 | Jatrorrhizine hydrochloride inhibits the proliferation and neovascularization of C8161 metastatic melanoma cells. ( Cao, Z; Guo, P; Liu, R; Pan, Y; Yang, P; Zhang, G; Zhou, Q, 2013) |
| "Berberine (BBR) is a natural isoquinoline alkaloid with proven antiangiogenic and anticancer activities." | 1.42 | Antiangiogenic and antitumor activities of berberine derivative NAX014 compound in a transgenic murine model of HER2/neu-positive mammary carcinoma. ( Bartozzi, B; Damiani, E; Donati, A; Geroni, C; Lombardi, P; Lucarini, G; Orlando, F; Pierpaoli, E; Provinciali, M; Salvatore, C, 2015) |
| "Berberine has several anti-inflammation and anticancer biologic effects." | 1.40 | Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells. ( Chen, KS; Chen, PN; Chu, SC; Hsu, LS; Su, MY; Yu, CC, 2014) |
| "Malignant melanoma is the most aggressive form of skin cancer." | 1.39 | Jatrorrhizine hydrochloride inhibits the proliferation and neovascularization of C8161 metastatic melanoma cells. ( Cao, Z; Guo, P; Liu, R; Pan, Y; Yang, P; Zhang, G; Zhou, Q, 2013) |
| "Berberine could also inhibit endothelial motility, migration, tube formation, and vessel sprouting from rat aortic ring in vitro." | 1.38 | Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators. ( Hamsa, TP; Kuttan, G, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ye, C | 1 |
| Liang, Y | 1 |
| Chen, Y | 1 |
| Xiong, Y | 1 |
| She, Y | 1 |
| Zhong, X | 1 |
| Chen, H | 1 |
| Huang, M | 1 |
| Yahuafai, J | 1 |
| Asai, T | 1 |
| Oku, N | 1 |
| Siripong, P | 1 |
| Liu, R | 1 |
| Cao, Z | 2 |
| Pan, Y | 2 |
| Zhang, G | 2 |
| Yang, P | 1 |
| Guo, P | 1 |
| Zhou, Q | 2 |
| Yu, D | 1 |
| Fu, S | 1 |
| Bao, M | 1 |
| Liu, W | 1 |
| Chu, SC | 1 |
| Yu, CC | 1 |
| Hsu, LS | 1 |
| Chen, KS | 1 |
| Su, MY | 1 |
| Chen, PN | 1 |
| Damiani, E | 2 |
| Pierpaoli, E | 2 |
| Orlando, F | 2 |
| Donati, A | 2 |
| Provinciali, M | 2 |
| Wang, N | 1 |
| Feng, Y | 1 |
| Tan, HY | 1 |
| Cheung, F | 1 |
| Hong, M | 1 |
| Lao, L | 1 |
| Nagamatsu, T | 1 |
| Lucarini, G | 1 |
| Bartozzi, B | 1 |
| Lombardi, P | 1 |
| Salvatore, C | 1 |
| Geroni, C | 1 |
| Hao, CY | 1 |
| Hamsa, TP | 1 |
| Kuttan, G | 1 |
10 other studies available for berberine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Berberine; Brain; Cerebrovascular Circ | 2021 |
Anticancer Efficacy of the Combination of Berberine and PEGylated Liposomal Doxorubicin in Meth A Sarcoma-Bearing Mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Berberine; Cell Line, Tumor; Doxorubicin; D | 2018 |
Jatrorrhizine hydrochloride inhibits the proliferation and neovascularization of C8161 metastatic melanoma cells.
Topics: Animals; Berberine; Cell Line, Tumor; Growth Inhibitors; Humans; Melanoma; Mice; Mice, Inbred BALB C | 2013 |
Unraveling the novel anti-osteosarcoma function of coptisine and its mechanisms.
Topics: Animals; Antigens, CD; Antineoplastic Agents, Phytogenic; Berberine; Bone Neoplasms; Cadherins; Cell | 2014 |
Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells.
Topics: Animals; Berberine; beta Catenin; Cell Line, Tumor; Cell Movement; Chickens; Chorioallantoic Membran | 2014 |
Sidestream dark field videomicroscopy for in vivo evaluation of vascularization and perfusion of mammary tumours in HER2/neu transgenic mice.
Topics: Angiogenesis Inhibitors; Animals; Berberine; Female; Mammary Glands, Animal; Mammary Neoplasms, Anim | 2015 |
Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Berberine; Carcinoma, Hepatocellular; Cell Line, Tumor; Drugs, Chine | 2015 |
Antiangiogenic and antitumor activities of berberine derivative NAX014 compound in a transgenic murine model of HER2/neu-positive mammary carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Berberine; Berberine Alkaloids; beta-Galactosidase; Bre | 2015 |
Angiogenesis blockade as therapy for hepatocellular carcinoma: progress and challenges.
Topics: Angiogenesis Inhibitors; Animals; Berberine; Carcinoma, Hepatocellular; Down-Regulation; Endothelial | 2011 |
Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators.
Topics: Angiogenesis Inhibitors; Animals; Berberine; Cell Line, Tumor; Down-Regulation; Gene Expression Regu | 2012 |